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ABSTRACT 
Arthrospira maxima and Chlorella vulgaris contain protein, carbohydrates, antioxidants, omega-3 fatty acids, and many 
micronutrients. Those compounds have potency of antidiabetic and hypolipidemic activity. This study aimed to 
evaluate the effect of A. maxima and C. vulgaris powder administration on alteration of body weight, lipid profile, 
glucose levels, and visceral fat index of hyperglycemia rats. Twenty male rats were divided into 5 groups i.e. negative 
control (NC), hyperglycemia control (HC), metformin (M), A. maxima (AR), and C. vulgaris (CH). Body weight and 
visceral fat index were measured and calculated by semianalytic and analytical scales. Serum glucose levels were 
measured by Easy Touch GCU (Glucose, Cholesterol, Uric acid). Lipid profile levels were measured using the 
photometric enzymatic method. The results showed no differences in body weight between groups, except in AR 
group was found significantly decreased in body weight on the 20th day. Glucose serum, total cholesterol, HDL and 
triglyceride levels in microalgae treatment groups were not significantly different be compare to control group. LDL 
levels of D30 significantly different from D0, but neither between groups. The visceral fat index of a control group 
was higher compared to that of a microalgae group and significantly different. In conclusion, the administration of 
microalgae A. maxima and C. vulgaris for 30 days are effective to reduce visceral fat index but not effective to 
maintain body weight, glucose level, as well as not effective to improve lipid profile. 
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INTRODUCTION 
In recent years, the prevalence of diabetes mellitus 
(DM) continues to increase and become a major 
health problem in all countries (Aizzat et al., 2010). 
Type 2 diabetes mellitus (T2DM) is the most 
common type of diabetes, around 90% total 
incidence of diabetes mellitus (Ekoe, 2019). T2DM 
develops through a combination of genes, and 
environmental factors arise as a manifestation of the 
hyperglycemia phenotype (Hupfeld & Olefsky, 
2016). Hyperglycemia is one of the main symptoms 
of DM. Pharmaceutical factory products which most 
widely used to overcome the state of hyperglycemia 
are metformin (Hossain & Pervin, 2018).  
 Nowadays, the demand of microalgae is 
increasing in the pharmaceutical field (Udayan et al., 
2017). Microalgae that are often used are Arthrospira 
and Chlorella, which contain important nutrients 
including carbohydrate, lipid, protein, nucleic acid, 
minerals (especially iron), γ-linolenic acid, and 
antioxidants (Udayan et al., 2017; Yousefi et al., 
2019).  
 Several studies have assessed the potential 
cytotoxic effects of Arthrospira in vitro. There were 
no adverse effects in rats that were fed A. maxima up 
to 30% in food for three months (Bigagli et al., 
2017). A meta-analysis conducted by Serban et al. 
(2016), showed a significant effect of 
supplementation with Arthrospira in reducing plasma 
concentrations of total cholesterol, LDL, 
triglycerides, and increasing HDL levels. 
 Chlorella's role is to prevent dyslipidemia in 
high-fat feed rats. The treatment for 8 weeks showed 
a decrease in total cholesterol, LDL, and triglyceride 
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levels (Jong-Yuh & Mei-Fen, 2005). Chlorella 
consumption is useful in preventing the 
development of type 2 diabetes mellitus. The 
research conducted by Aizzat et al. (2010), showed 
that the administration of Chlorella vulgaris during 4 
weeks in diabetic rats has no hypoglycemic effect but 
has a protective function against STZ-induced rats 
by reducing oxidative DNA damage and lipid 
peroxidation. 
 Measurement of serum cholesterol levels has a 
major function in the diagnosis and treatment of 
several diseases such as cardiovascular disease, 
hypothyroidism, and diabetes (Narwal et al. 2019). In 
some studies, there is a relationship between lipid 
profile levels and type 2 diabetes (Pantoja-Torres et 
al., 2019). Therefore, this study aimed to evaluate the 
effect of A. maxima and C. vulgaris administration for 
30 days to serum lipid profile, visceral fat index, 
glucose serum level, and body weight of 
hyperglycemia rats induced by single low-dose of 
streptozotocin.  
 
MATERIALS AND METHODS 
Microalgae A. maxima and C. vulgaris powder were 
obtained from Blue-Green Algae Biotechnology. 
Male Wistar rats at 15 weeks old, 200-300 gram body 
weight from Integrated  Laboratory Research and 
Testing (Laboratorium Penelitian dan Pengujian 
Terpadu, LPPT) UGM. This research was approved 
by UGM Animal Ethics Commission with certificate 
number 00167/04/LPPT/1/2018.  
 
Experimental Design  
The animal models were maintained in middle 
photoperiode (12L-12D cycles) and room 
temperature. The rats routine feed and drinking with 
Reverse Osmosis (RO) water ad libitum. The twenty 
male rats were randomly divided into five groups 
with 4 replicants. Every group of animals were taken 
care of in a communal cage and acclimated for a 
week. A group of rats for normal control (NC). Four 
other groups were induced hyperglycemia using 
single low-dose of STZ was 30 mg/kg b.w. in 0.1 M 
citrate buffer pH 4.5 intraperitoneally. After that, 
without any other treatments for hyperglycemia 
control (HC) group. Metformin (M) group treated 
with metformin 10 mg/kg b.w. as medical treatment. 
AR group treated with A.  maxima 2,500 mg/kg b.w. 
CH group treated with Chlorella vulgaris 2,500 mg/kg 
b.w. Blood glucose levels were measured three days 
and seven days after induction. This level of glucose 
later was marked as day 0 (0th). Metformin and 
microalgae were given orally once a day at 3.00 p.m. 
- 4.00 p.m. The treatment lasts for 30 days.  
 
  
Body weight and Visceral Fat Index  
Body weight was measured every 10 days. At the end 
of the experiment, the rats were anesthetized briefly 
before sacrificed. The adipose tissues were collected 
and measured its weight to obtained visceral fat 
index. Visceral fat index was calculated using the 
formula below: 
           (1) 
 
Biochemical Analysis  
Serum glucose level and serum lipid profile were 
measured at the start, 15th, and 30th days.  Blood 
samples were collected from the supra-orbital sinus 
of rats after 8 hours fast. Serum glucose level 
measured using Easy Touch GCU (Glucose, 
Cholesterol, Uric acid). Lipid profile consists of total 
cholesterol, HDL-C, LDL-C, and triglycerides. Total 
cholesterol was measured using enzymatic 
photometric CHOD-PAP method. While HDL-C, 
LDL-C, and TG were measured using enzymatic 
photometric GPO method.  
 
Statistical Analysis  
Body weight, blood glucose level, and lipid profile 
data were analyzed using One way ANOVA, 
followed by Duncan test at a significance level of 5% 
 
RESULTS AND DISCUSSION 
The results of this research are body weight, serum 
glucose level, lipid profile, and visceral index shown 
at the figures and tables below. The age of rats used 
was 15 weeks with high carbohydrate diet in the 
previous research period (Hartantyo et al., 2018). 
Hartantyo et al. (2018) showed that high 
carbohydrate diet caused metabolic disorders such as 
obesity and hyperglycemia. In obese animals, insulin 
resistance can increase with age (King & Austin, 
2017). Microalgae used in the study were A. maxima 
and C. vulgaris. Some nutrients in A. maxima and C. 
vulgaris are omega 3, omega 6, linoleic acid, EPA, 
DHA, tannins, saponins, Zn, and Fe (Widiyanto et 
al., 2018). There were no adverse effects or negative 
effects during the treatment. All of the test animals 
were kept alive during the treatment. 
 
Body Weight 
Body weight of the test animal measurements were 
used as a parameter for growth. The body weight 
range of rats was 200-300 grams to minimize 
mortality (Mu'allimah, 2017). The body weight rats 
of all groups continued to increase until the 30th day. 
Body weight gain was linear with age (Stevani, 2017). 
Fluctuations showed in body weight gain or decrease 
during microalgae and metformin intervention 
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(Figure 1.) However, there were no significant 
differences between the treatment groups at ∆1 and 
∆3. Whereas at ∆2, the Arthrospira maxima group had 
a significant decrease in weight. ∆ : the difference 
between two data; ∆1: body weight difference 
between D0 and D10; ∆2: body weight difference 
between D10 and H20; ∆3: body weight difference 
between D20 and D30. 
 
 
Figure 1. Body weight of hyperglycemia Wistar male rats 
(Rattus norvegicus Berkenhout, 1769) treated with A. 
maxima and C. vulgaris for 30 days; ∆1: BW difference 
between D0 and D10; ∆2: BW difference between D10 
and H20; ∆3: BW difference between D20 and D30; ** = 
significantly different between groups, ^ = significantly 
different between deltas. NC: negative control, HC: 
hyperglycemia control, M: metformin, AR: A. maxima, 
and CH: C. vulgaris  
 
 The smallest or lowest weight gain was at ∆2. 
This is related to high serum glucose levels in D10 to 
D20 (day 10 and day 20 of treatment) and rats 
undergoing early diabetes. So that the increase of 
body weight was only slightly due to the limitations 
of cells utilizing glucose to be converted into energy. 
At the end of the treatment, blood glucose levels had 
improved so that the body weight began to increase 
again even though the increase in body weight was 
lower than at the beginning of the treatment. Body 
weight reductions of 1.70 ± 0.48% and 0.45 ± 
1.11% in the AR and CH groups, respectively, can 
be caused by the saponin in both microalgae. 
Although it can not be certain that saponin is the 
single cause. According to Stevani (2017), saponins 
can suppress and maintain body weight in the 
normal range by inhibiting the activity of the 
pancreatic lipase enzyme thereby preventing the 
accumulation of fat in the body.  
 
Serum Glucose Levels  
Streptozotocin (STZ) has been widely used to induce 
hyperglycemia in experimental animals by inhibit 
insulin secretion because it is analogous to glucose 
(Radenkovic et al., 2015). Pancreatic beta cells have a 
high concentration of glucose transporter 2 
(GLUT2). STZ has the same structure with glucose, 
so it will absorbted by pancreatic beta cells (Papich, 
2016).  
 In this study, induction of hyperglycemia was 
used single low-dose 30 mg/kg b.w. of STZ.  Some 
previous studies used higher STZ dose variations to 
induce type 2 diabetes mellitus (Ghadge et al., 2016; 
Rouhi et al., 2017). Meanwhile, according to 
Radenkovic et al (2015), the most widely dose used 
to induce diabetes is 35-80 mg/kg b.w. 
intraperitoneally and 35 mg/kg b.w. intravenously. 
The recommended dose is 60 mg/kg b.w. 
intraperitoneally. Based on these recommendations, 
it can be assumed that the effect of a single low-dose 
STZ induction will only temporarily increase glucose 
levels. 
 The decreased of glucose levels in the HC 
group was happen because this is still the initial stage 
Table 1. Serum glucose level of hyperglycemia Wistar male rats (Rattus norvegicus  Berkenhout,1769) treated with A. 
maxima and C. vulgaris on days (-7), 0, 15, and 30 of treatments 
Group 
Serum Glucose Level (mg/dL) 
∆ (D30-D0) (%) 
D(-7) D0 D15 D30 
NC 81.25 ± 12.69a,x 87.00 ± 4.08a,x 105.50 ± 10.60a,y 95.75 ± 8.77a,xy  10.06 ± 10.88 
HC 249.50 ± 99.95c,x 295.75 ± 55.09b,x 183.75 ± 104.98a,x 185.75 ± 75.26a,x  -37.19 ± 17.03 
M 237.25 ± 105.75bc,x 292.00 ± 134.32b,x 192.75± 82.10a,x 223.25 ± 127.06a,x -23.54 ± 39.92 
AR 189.50 ± 14.39bc,x 210.25 ± 79.19ab,x 175.25 ± 62.95a,x 187.25 ± 110.62a,x  -10.94 ± 107.28 
CH 139.25 ± 33.46ab,x 277.25 ± 185.48b,x 142.25 ± 62.89a,x 152.75 ± 68.16a,x  -44.91 ± 33.88 
Note : a,b,c = differences between days, x,y,z = differences between groups, (-) = decreasing of levels, bold : significant 
differences between groups or days, NC : negative control, HC : hyperglycemia control, M : metformin, AR : A. 
maxima, and CH : C. vulgaris 
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of induction to diabetes, so that insulin resistance 
and impaired glucose tolerance can still return to 
normal glucose tolerance (Hupfeld & Olefsky, 2016). 
Whereas in the M and AR groups respectively 
decreased by 23.54 ± 39.92% and 10.94 ± 107.28% 
(Table 1.). The cause of decreased serum glucose 
levels in the microalgae group is explained as 
follows. According to Jong-Yuh & Mei-Fen (2005), 
Chlorella can reduce glucose levels by reducing the 
level of DNA damage and lipid peroxidation. 
Whereas according to Vo et al. (2015), the water-
soluble Arthrospira fraction is effective in reducing 
serum glucose levels in a fasting state. 
 
Lipid Profile 
Lipid profiles are the main data for this research. 
Acording to Table 2. showed the normal levels for 
each of the Wistar rat lipid profile parameters (Rattus 
norvegicus Berkenhout,1769) for males (Stevani, 2017) 
and females (Karima & Mulyati, 2019). Normal 
levels showed as two normal line in the result’s 
figures, that is upper and lower normal limits. 
 
Table 2. Normal ranges of lipid profile parameters in 
male and female Wistar rats (Rattus norvegicus 
Berkenhout,1769)  
 
 
Total Cholesterol Levels  
Cholesterol is part of lipids, with the main structure 
of steroids. Cholesterol is the basic structure for the 
synthesis of steroid hormones such as estradiol, 
progesterone, testosterone, and cortisol. Cholesterol 
levels in the blood are closely related to the 
dynamics of steroid hormone levels. It is also related 
to the individual reproduction phase and stress 
conditions.  Cholesterol levels in the blood of test 
rats with the treatment of A. maxima and C.vulgaris 
are presented in the Table 3. 
 Based on Table 3., total cholesterol level of the 
microalgae group was higher than the HC and M 
groups, and almost the same as the NC group at the 
end of the treatment (D30). Total cholesterol levels 
of the HC group increased in D0. This is linear to 
statement of Rouhi et al. (2017) that the state of 
diabetes can increase total cholesterol levels. An 
Lipid Profile 
Parameters 
Normal range of lipid profile 
levels (mg/dL) 
Karima & 
Mulyati, 2019 
Stevani, 2017 
Total cholesterol 
levels 
75.86 – 82.00 53.70 – 73.60 
HDL-C levels 59.08 – 64.60 14.90 – 30.90 
LDL-C levels 53.72 – 57.92 18.70 – 36.90 
Triglycerides levels 46.10 – 65.52 48.00 – 167.00 
increase of total cholesterol levels in hyperglycemia 
individuals due to the state of insulin resistance can 
reduce the level of cholesterol absorption (Andrade 
et al., 2019). Even the CH groups in D15 and D30 
were slightly higher than normal levels of total 
cholesterol (Stevani, 2017). NC group levels also 
exceed normal levels at D0 and D30. However, 
when viewed from D15, the total cholesterol level in 
the CH group was lower at D30. The increase and 
decrease are not significantly difference. 
 Cholesterol levels of negative control and 
microalgae group higher than the hyperglycemia 
control group caused by high cholesterol synthesis 
and absorption (Andrade et al., 2019), as well as the 
accumulation of cholesterol metabolism in the body 
(Stevani, 2017). An increase in cholesterol levels also 
caused by an increase in LDL levels. This is related 
to the function of LDL as a cholesterol transporter 
from the liver to the peripheral cells. Therefore, 
factors that influence total LDL concentrations will 
affect total cholesterol. So, an increase in LDL levels 
is proportional to an increase in total cholesterol 
levels (Arifah, 2006). 
 
HDL-C levels  
At D30, all groups except AR group showed an 
increase in HDL levels. NC and CH groups had 
HDL levels exceeding the normal range. The group 
with the highest HDL levels was Chlorella group, 
followed by the negative control, Arthrospira, 
hyperglycemia control, and metformin group (Table 
4.).  
 According to Tabel 4. when compared 
between the two microalgae groups, the Chlorella 
vulgaris group (CH group) has higher HDL-C levels 
than AR group. The omega 3 content may be higher 
in Chlorella than Arthrospira. The results are 
consistent with the statement of Harris & Jacobson 
(2009), that omega 3 has a minor effect on HDL 
however, omega 3 can increase HDL levels, 
although not significantly. Mechanisms that possible 
to increase HDL levels are HDL receives cholesterol 
from peripheral cells and takes it to the liver for bile 
production (Wickramasinghe & Weaver, 2018). 
HDL has two mechanisms in transporting 
cholesterol esters to the liver i.e. direct and indirect 
reverse transport. Reverse transportation is indirectly 
mediated by Cholesterol Esters Transfer Protein 
(CETP) (Jim, 2013). According to Purnomo (2014), 
omega-3 can reduce CETP activity so that the 
transfer of ester cholesterol from HDL to VLDL, 
IDL, and LDL also decreases. In addition, according 
to Riggs and Rohatgi (2019), Apo A1 is the main 
protein constituent of HDL particles, mediating 
reverse cholesterol transport. Then decrease the 
concentration of VLDL and apo B due to the fall of 
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CETP which is influenced by omega-3. This result 
has implications for the secretion of apo B and 
VLDL which slows down into circulation or faster 
VLDL catabolism in the liver (Ryu et al., 2014). So 
that HDL levels increase. 
 
LDL-C Levels  
LDL lipoprotein is commonly used as an indicator 
of health-related to the heart and blood vessels. LDL 
is a part of lipid in blood circulation that carries a lot 
of cholesterol and triglyceride components. The two 
components have a large proportion, consequently 
forming molecules that are also large. In blood 
circulation, this is often seen as a barrier to the rate 
of circulation.  The measurements of LDL-C levels 
of this research at D0, D15, and D30 were showed 
in Table 5. 
 Based on Table 5., all groups have a significant 
difference increase in LDL-C levels when compared 
to D0. According to previous research, A. maxima 
and C. vulgaris have the effect of lowering LDL 
cholesterol levels (Jong-Yuh & Mei-Fen, 2005; 
Torres-Duran et al., 2007; Karima & Mulyati, 2019). 
The results in this study are not in accordance with 
the study. However, based on a meta-analysis in 
patients with type 2 diabetes who were given an 
omega-3 diet, they have a significant difference 
increase of LDL cholesterol levels (Chaves et al., 
2019).  
 LDL cholesterol increase caused by two 
things: an increase in the number of LDL particles 
or an increase in LDL particle size, with each particle 
carrying more cholesterol. Larger LDL particles are 
less atherogenic than smaller particles, the denser 
characteristics found in the hypertriglyceridemia 
state (Harris & Jacobson, 2009). This is in 
accordance with Purnomo (2014), which states that 
in the process of catabolism of VLDL to LDL, there 
are two types of LDL produced, large VLDL will 
produce small, dense, and atherogenic LDL. 
Whereas a small VLDL will produce large and non-
atherogenic LDL. In Metformin groups, the 
difference in increasing LDL-C is the highest 
compared with the other groups. Metformin has an 
effect on reducing blood glucose levels. Through 
certain mechanisms, then blood glucose is converted 
to triglycerides so that levels gradually increase with 
time. In group Microalgae, there was a slight increase 
compared to control.   
 
Triglyceride Levels 
Triglycerides are part of a lipid with a structured 
form of glycerol and fatty acids. In general, high 
triglyceride levels also indicate an unhealthy 
circulation system. Associated with LDL-C levels, 
the possibility of triglycerides is moving dynamically 
on free TG with TG on LDL-cholesterol (LDL-C). 
The results of measurements of triglyceride levels at 
D0, D15, and D30 are shown in Table 6.  
 Triglyceride levels in the microalgae group 
were lower than the hyperglycemia group. Whereas 
in the metformin group the triglyceride levels were 
higher but also decreased in D30. This is caused by 
the ability of metformin to improve glucose levels. 
Increasing the utilization of peripheral glucose has 
the potential to reduce the production of fatty acids 
and triglycerides (Srinivasan et al., 2018). C. vulgaris 
can lower triglyceride levels better than A. maxima 
because the ratio of omega-6 / omega-3 to C. vulgaris 
is lower than A. maxima (Gonzalez-Periz et al., 2009; 
Zanwar et al., 2018) 
 Previous studies have revealed that Arthrospira 
and Chlorella can reduce triglyceride levels (Jong-Yuh 
& Mei-Fen, 2005; Ou et al., 2012; Karima & Mulyati, 
2019). The decrease of triglyceride levels may be 
influenced by omega-3 content in both microalgae 
(Ghadge et al., 2016). Chlorella is a good source of 
dietary fiber that affects lymphatic cholesterol and 
triglyceride absorption by increasing intestinal 
viscosity, changing the composition of bile acid 
pools or producing fermented products in the 
intestine (Ryu et al., 2014). 
 A potential mechanism by which omega-3 
fatty acids (FA) in both microalgae were affecting 
hepatic triglyceride (TG) metabolism. Feeding 
omega-3 FA in mice has been shown can inhibit 
lipogenesis and diacylglycerol acyltransferase 
( D GA T)  a c t i v i t y ,  p ho sph a t i d i c  a c i d 
phosphohydrolase (PA), and hormone-sensitive 
lipase; and to stimulate oxidation, phospholipid 
synthesis, and degradation of apolipoprotein (apo) B. 
The result is a very low level of TG lipoprotein 
(VLDL) secretion. Nonesterified fatty acid serum 
(NEFA) also provides FA for TG synthesis (Harris 
& Jacobson, 2009). 
 
Visceral Fat Index  
The visceral fat index shows the amount of fat 
found in the abdominal cavity. The fat appears to 
envelop or cover the internal organs. These fats can 
indicate the presence of excess glucose in the blood 
that is in a chronic state, the glucose is then 
converted to glycogen and fat. The visceral fat index 
is often associated with metabolic syndrome, 
impaired lipid and glucose metabolism, and 
cardiovascular disease (Hameed & AbdulQahar, 
2019). It is a good predictor of visceral adiposity 
associated with T2DM. Serves as an indicator of fat 
distribution and an indicator of adipose tissue 
function that can change due to insulin resistance 
(Babiker et al., 2018).  
 The visceral fat index of hyperglycemia group 
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Table 3. Total cholesterol level of hyperglycemia male Wistar rats (Rattus norvegicus Berkenhout, 1769) with  A. 
maxima and C. vulgaris treatment on days 0, 15, and 30 of treatments.  
Note : a,b,c = differences between days, x,y,z = differences between groups, (-) = decreasing of levels, bold : significant 
differences between groups or days, NC : negative control, HC : hyperglycemia control, M : metformin, AR : A. 
maxima, and CH : C. vulgaris 
 
Table 4. HDL cholesterol levels of hyperglycemia male Wistar rats (Rattus norvegicus Berkenhout, 1769) with A. 
maxima and C. vulgaris treatment  during 30 days. 
Groups 
Total Cholesterol Levels (mg/dL) 
∆ (D30-D0) (%) 
D0 D15 D30 
NC 77.50 ± 12.34a,x 68.68 ± 6.05a,x 74.20 ± 9.50a,x -4.26 ± 5.62 
HC 59.68 ± 10.17a,x 69.43 ± 8.24a,x 67.60 ± 11.09a,x 13.27±12.97 
M 58.98 ± 11.08a,x 61.90 ± 14.05a,x 67.03 ±16.40a,x 13.65 ± 0.09 
AR 67.90 ± 4.24a,x 68.78 ±11.66a,x 73.48 ± 21.08a,x 8.22 ± 31.52 
CH 70.35 ± 16.89a,x 75.65 ± 16.72a,x 74.78 ± 12.70a,x 6.30 ± 21.49 
Groups 
HDL-C Levels (mg/dL) 
∆ (D30-D0) (%) 
D0 D15 D30 
NC 34.18 ± 6.76ab,x 36.83 ± 4.21a,x 34.20 ± 4.54a,x 0.06 ± 8.34 
HC 29.30 ± 6.73a,x 33.18 ± 3.22a,x 30.18 ± 3.54a,x 3.00 ± 22.28 
M 26.60 ± 3.98a,x 29.88 ± 4.38a,x 30.05 ± 4.89a,x 12.97 ± 18.43 
AR 39.35 ± 5.56c,x 32.93 ± 4.66a,x 33.83 ± 6.54a,x -14.03 ± 28.31 
CH 35.78 ± 7.20ab,x 35.48 ±5.54a,x 40.50 ± 13.15a,x 13.19 ± 42.22 
Note : a,b,c = differences between days, x,y,z = differences between groups, (-) = decreasing of levels, bold : significant 
differences between groups or days, NC : negative control, HC : hyperglycemia control, M : metformin, AR : A. 
maxima, and CH : C. vulgaris 
 
Table 5. LDL-cholesterol levels of hyperglycemia male Wistar rats (Rattus norvegicus Berkenhout,1769) treated with A. 
maxima and C. vulgaris during 30 days 
Groups 
LDL-C Levels (mg/dL) 
∆ (D30-D0) (%) 
D0 D15 D30 
NC 14.65 ± 2.45a,x 22.80 ± 2.32a,y 23.78 ± 3.47a,y 62.32 ± 19.82 
HC 13.13 ± 3.83a,x 23.68 ± 4.91a,y 21.55 ± 2.59a,y 64.13 ± 58.42 
M 10.95 ± 3.00a,x 20.10 ± 0.16a,y 23.58 ± 2.93a,y 115.34 ± 63.80 
AR 12.63 ± 2.21a,x 21.05 ± 5.14a,x 20.70 ± 9.87a,x 63.90 ± 96.39 
CH 13.43 ± 5.14a,x 22.60 ± 5.30a,y 22.65 ± 4.15a,y 68.65 ± 78.60 
Note : a,b,c = differences between days, x,y,z = differences between groups, bold : significant differences between groups 
or days, NC : negative control, HC : hyperglycemia control, M : metformin, AR : A. maxima, and CH : C. vulgaris 
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showed the lowest compared to other groups 
especially normal control or nomale group. Visceral 
fat index of all groups was lower than normal 
controls. All hyperglycemia treatment groups 
became less fatty. This may be due to the body cells 
experiencing glucose deficiency so that there is no 
conversion to glycogen or fat. The results of 
treatment with A maxima and C. vulgaris are better 
than hyperglycemia conditions. Furthermore, 
between the two kinds of microalgae, A maxima is 
better than C vulgaris (Figure 2.).  
 
 
Figure 2. Visceral fat index of hyperglycemia male 
Wistar rats (Rattus norvegicus Berkenhout, 1769) treated 
with A. maxima and C. vulgaris after 30 days of treatment; 
sign (**) = significantly different between treatment 
groups. NC : negative control, HC : hyperglycemia 
control, M : metformin, AR : A. maxima, and CH : C. 
vulgaris 
 
 According to Eckel (2018), the main sites for 
the regulation of insulin and glucagon are liver, fat 
tissue, and muscle. The liver functions in the process 
of glycogenesis, glycogenolysis, gluconeogenesis, and 
ketogenesis. While fat cells function for lipolysis 
(Eckel, 2018). Because there is a disruption in energy 
production, alternative energy sources are used, 
namely the adipose tissue. So the adipose tissue mass 
in the HC group is low. 
 Increasing the utilization of peripheral glucose 
has the potential to reduce the production of fatty 
acids and triglycerides (Srinivasan et al., 2018). The 
results of this study indicate that the omega-3 
content reduces triglyceride levels. When triglyceride 
levels go down, triglyceride stores in adipose tissue 
will also decrease. Therefore, the visceral fat index in 
the microalgae group was lower than the NC group 
but was already higher than the HC visceral fat index 
due to induction hyperglycemia using metformin and 
microalgae. 
 
CONCLUSION 
In conclusion, the administration of microalgae A. 
maxima and C. vulgaris were effective to reduce the 
visceral fat index but not effective to maintain body 
weight, glucose serum levels, as well as not effective 
to improve lipid profile. 
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